china: 267, life: 31, sciences: 24, health: 63, care: 35, market: 147, whitepaper: 55, september: 2, lshc: 171, mirror: 32, preface: 2, findings: 2, overview: 2, deals: 74, value: 99, leading: 17, chinese: 29, biopharma: 41, biotech: 62, players: 17, attracting: 7, global: 29, investors: 29, industry: 49, advancing: 3, unprecedented: 3, speed: 4, proliferation: 3, services: 65, surge: 5, substitution: 6, phenomenon: 5, medical: 142, devices: 42, financings: 10, divergent: 3, performance: 5, listed: 13, companies: 60, hkex: 29, star: 15, development: 57, consolidating: 5, investment: 61, flows: 5, trends: 26, forecast: 10, business: 15, opportunities: 8, driven: 12, digitalization: 11, innovation: 36, driving: 5, growth: 34, fundraising: 16, localizing: 2, every: 3, aspect: 2, hospital: 45, integration: 14, create: 7, brand: 9, effect: 7, changing: 3, population: 13, structure: 4, usher: 2, senior: 15, needs: 5, conclusion: 3, appendix: 17, mergermarket: 26, deal: 82, database: 3, criteria: 15, additional: 3, information: 15, endnotes: 4, contacts: 3, healthcare: 37, resurgence: 3, volume: 53, despite: 5, substantial: 4, economic: 4, social: 2, disruptions: 2, outbreak: 9, first: 12, half: 5, year: 14, public: 39, quick: 2, emergency: 3, stimulus: 2, strong: 12, exports: 2, activities: 6, helped: 3, recover: 3, quickly: 4, resume: 2, versus: 2, decline: 2, world: 15, period: 4, according: 4, statistics: 3, pandemic: 16, certainly: 2, also: 27, continued: 4, research: 49, technological: 3, advances: 5, sector: 17, whole: 3, report: 19, looks: 2, activity: 25, largest: 12, understand: 2, drivers: 3, behind: 2, themes: 2, financing: 4, landscape: 2, stage: 5, although: 7, pivotal: 2, novel: 7, drugs: 32, biotechnology: 18, increases: 3, transactions: 24, inbound: 5, investments: 28, domestic: 32, step: 5, change: 5, quality: 5, medtech: 7, past: 5, years: 20, rise: 4, amount: 2, capital: 46, funding: 9, momentum: 2, building: 8, wave: 4, series: 13, national: 18, policies: 11, regulatory: 4, reform: 9, drug: 21, administration: 6, today: 2, expected: 8, grow: 5, prominent: 2, innovative: 17, participants: 5, looking: 4, ahead: 3, plan: 8, recent: 11, identifying: 2, five: 12, main: 8, focus: 6, preventive: 7, infusion: 3, certain: 2, consolidation: 5, branded: 4, groups: 3, challenges: 4, expect: 6, sustain: 4, long: 3, term: 4, potentially: 2, increased: 6, continue: 10, advance: 3, consolidate: 3, back: 5, four: 7, major: 10, traits: 2, identified: 3, time: 7, furthermore: 3, seen: 7, successfully: 2, going: 4, share: 5, listing: 15, showing: 6, observed: 3, ongoing: 3, three: 12, regions: 2, yangtze: 3, river: 4, delta: 3, greater: 7, area: 5, region: 12, attracted: 6, financial: 11, fast: 3, recovery: 3, many: 16, funds: 8, injected: 3, especially: 15, fields: 6, licensing: 3, reflect: 4, previous: 9, predicted: 5, trend: 10, develop: 6, local: 19, receiving: 3, attention: 3, industrial: 11, increase: 11, related: 18, science: 10, field: 4, support: 16, pharma: 9, actually: 2, found: 3, brought: 2, ihealth: 8, accelerated: 9, became: 2, biggest: 2, hotspot: 2, technology: 24, upsurge: 3, segment: 5, promotion: 5, replace: 2, imported: 5, ones: 5, compared: 3, theme: 2, result: 8, disease: 16, opportunity: 2, epidemic: 4, generation: 5, therapy: 9, hospitals: 49, group: 24, enhance: 3, response: 4, aging: 4, active: 12, influence: 3, favorable: 4, record: 4, high: 6, full: 4, figure: 46, reached: 12, including: 20, mega: 8, billion: 30, level: 8, excluding: 2, remained: 4, quite: 2, foreign: 7, excludes: 13, note: 19, disclosed: 16, inclusion: 13, source: 39, deloitte: 68, often: 4, becoming: 6, proactive: 2, entered: 4, positive: 4, dominated: 3, shows: 2, vaccine: 12, policy: 6, government: 29, encouraged: 4, scientific: 2, innovations: 5, combined: 4, respectively: 3, total: 15, others: 7, accounting: 3, representative: 4, included: 11, beachhead: 3, consortiums: 2, acquisition: 18, stake: 24, biologic: 4, products: 31, cbpo: 3, company: 21, tech: 12, round: 7, sino: 6, biopharmaceutical: 9, purchase: 6, sinovac: 7, hillhouse: 16, southern: 5, shuanglin: 5, harbin: 4, pafc: 3, zhejiang: 20, traditional: 9, medicine: 15, conba: 8, resources: 24, pharmaceutical: 32, boya: 4, jizhong: 5, energy: 5, taking: 4, north: 3, viva: 7, langhua: 5, joincare: 7, mainly: 3, escalating: 2, trade: 2, however: 7, outbound: 4, target: 14, cancer: 3, popular: 3, targets: 6, overseas: 9, enterprises: 7, stable: 2, internet: 14, providers: 3, expanding: 3, online: 21, consultation: 2, pharmacy: 2, payment: 9, opened: 2, digital: 34, direction: 2, inner: 3, ring: 6, outer: 2, went: 4, competition: 2, prescription: 2, prompted: 3, expand: 8, product: 10, lines: 5, mergers: 2, acquisitions: 10, implementation: 2, invoice: 2, system: 9, procurement: 5, squeezed: 2, small: 7, prompting: 2, accelerate: 4, factors: 5, strategic: 11, cases: 4, opening: 2, board: 2, shanghai: 15, chinext: 2, hong: 6, kong: 6, stocks: 3, regulations: 5, holdings: 5, management: 25, stock: 5, exchange: 2, attractive: 3, delisted: 2, private: 15, began: 3, fundraisings: 6, listings: 6, involving: 5, platforms: 10, involved: 4, date: 9, announced: 8, bidder: 5, notes: 4, citic: 4, international: 10, nasdaq: 3, production: 16, capability: 3, equity: 11, asset: 11, green: 2, gtja: 2, fund: 6, application: 5, submitted: 2, could: 7, become: 9, domestically: 2, focused: 3, gene: 9, history: 2, since: 11, million: 27, patients: 10, microport: 4, grand: 2, planned: 2, raise: 2, creating: 3, huge: 5, demand: 8, tencent: 5, partners: 5, potential: 4, prospects: 2, cooperation: 2, parties: 3, table: 18, dirui: 2, shenzhen: 4, testing: 2, transaction: 10, important: 6, improve: 6, layout: 4, orbimed: 2, cormorant: 2, octagon: 2, lemzoparlimab: 3, abbvie: 6, authorized: 3, channels: 4, chronic: 7, boost: 3, everest: 4, medicines: 4, janchor: 2, made: 6, breakthrough: 2, launch: 3, antibody: 2, approved: 5, existing: 2, areas: 9, diseases: 5, infectious: 2, shougang: 4, took: 3, center: 14, make: 4, build: 3, district: 18, multiple: 3, continuous: 2, supply: 2, blood: 4, vitality: 2, seller: 2, coronavac: 4, developed: 3, produced: 2, find: 2, points: 2, help: 10, transformation: 7, completed: 5, advantage: 3, distribution: 6, leverage: 6, enables: 9, entire: 5, chain: 5, manufacturing: 7, import: 6, export: 5, based: 7, platform: 4, advantages: 2, profitability: 2, enhancement: 2, achieve: 3, synergies: 3, capacity: 7, position: 5, obtain: 3, across: 8, channel: 2, enter: 4, maxim: 2, biotechnologies: 6, beijing: 10, insurance: 5, instrument: 2, enrich: 2, risk: 5, resistance: 2, customer: 2, businesses: 5, overall: 4, vertical: 3, expansion: 5, cdmo: 4, geographic: 3, coverage: 3, preferred: 3, partner: 2, yichang: 4, humanwell: 7, subsidiary: 4, core: 7, competitiveness: 3, takeda: 4, hasten: 2, enable: 5, presence: 2, reduce: 4, taiji: 2, chongqing: 5, assets: 4, operation: 3, strengthen: 2, bringing: 3, even: 2, exceeded: 3, figures: 2, among: 2, countries: 6, contributed: 3, rebound: 2, average: 6, size: 5, connect: 2, gracell: 2, cardioflow: 2, therapeutics: 9, ipos: 8, harbour: 2, biomed: 2, applications: 4, type: 2, count: 3, cross: 6, border: 6, amgen: 2, beigene: 7, raas: 2, grifols: 3, diagnostic: 2, solutions: 2, agreement: 4, baring: 2, asia: 5, acquire: 13, lumenis: 2, enterprise: 2, held: 2, steady: 2, lower: 3, surged: 2, peak: 3, emea: 2, apac: 2, direct: 3, junshi: 7, collaboration: 3, revitope: 3, next: 5, immunotherapies: 2, targeted: 2, engaging: 2, transferee: 3, transferor: 3, upfront: 2, milestone: 2, oncology: 6, antibodies: 2, revealed: 7, royalties: 34, biosciences: 2, cstone: 4, pharmaceuticals: 5, fosun: 2, commercialization: 5, show: 3, continues: 3, attract: 2, interest: 4, giants: 9, ability: 2, markets: 3, competency: 2, innovent: 5, cell: 11, lilly: 3, jacobio: 2, henlius: 2, pharmacube: 2, last: 5, outlook: 2, noted: 2, increasing: 9, emphasis: 3, encouraging: 2, promising: 3, bnusd: 2, face: 2, smart: 7, fight: 2, coronavirus: 2, normal: 2, seven: 3, reforms: 4, almost: 2, number: 18, worldwide: 2, higher: 3, general: 8, leader: 7, generics: 4, manufacturers: 5, invest: 2, consistency: 2, burgeoning: 2, increasingly: 6, extending: 2, pipelines: 2, strengthening: 2, biologics: 2, promoted: 2, authorities: 4, introduced: 3, commercial: 3, revisions: 2, measures: 2, registration: 4, evaluation: 3, approval: 5, clinical: 11, trial: 3, council: 2, technical: 2, requirements: 2, centers: 6, patents: 2, facilitate: 2, talent: 3, knowledge: 4, expense: 2, give: 2, incentives: 2, innovate: 2, respect: 2, available: 3, patient: 2, trials: 5, comprehensive: 5, framework: 2, registered: 3, inflows: 2, march: 6, service: 6, establishing: 4, ventures: 5, instance: 3, edigene: 2, university: 2, using: 2, venture: 2, addition: 9, large: 14, joint: 3, wuxi: 2, apptec: 2, raised: 6, november: 2, immuneonco: 3, legend: 3, sale: 3, around: 8, genecradle: 2, angel: 4, immunotech: 2, biopharm: 2, strategy: 6, innorna: 2, immuno: 2, carsgen: 2, rising: 3, biopharmaceuticals: 2, vaccines: 8, ease: 2, inactivated: 3, country: 3, anhui: 2, cansino: 4, vero: 3, sinopharm: 3, wuhan: 3, india: 2, institute: 2, kazakhstan: 2, biological: 4, several: 6, rules: 2, june: 7, team: 2, notable: 3, include: 5, consortium: 2, agreed: 7, promoting: 4, capabilities: 2, cooperative: 2, introduce: 2, therapeutic: 2, used: 6, establish: 2, infrastructure: 4, would: 3, making: 4, contract: 4, organization: 5, offering: 3, therapies: 3, double: 5, surveyed: 2, operating: 4, tend: 2, favor: 2, prefer: 2, third: 4, artificial: 2, intelligence: 3, doubled: 2, much: 2, baidu: 3, wind: 14, representing: 3, consultations: 3, visits: 3, clinics: 2, particularly: 2, standards: 3, awareness: 3, need: 3, early: 4, prevention: 7, treatment: 3, discussed: 2, people: 15, another: 5, investing: 2, highly: 2, exploration: 2, started: 2, still: 7, grew: 4, starting: 2, clear: 3, open: 2, agencies: 2, issued: 2, role: 3, delivery: 2, height: 2, responded: 2, cities: 4, hangzhou: 3, chengdu: 3, allowing: 3, payments: 2, given: 5, benefits: 4, telemedicine: 9, scope: 2, treatments: 3, along: 2, diagnosis: 2, data: 8, institutions: 4, historically: 4, likely: 5, secure: 2, assistance: 2, makes: 2, rapidly: 5, rate: 10, traditionally: 2, extremely: 3, teleconferencing: 2, decided: 2, permanent: 2, access: 4, user: 3, consumer: 2, boom: 2, ping: 7, good: 7, doctor: 6, users: 2, received: 3, revenue: 7, wedoctor: 4, annual: 11, barriers: 2, citizens: 3, rural: 8, remote: 4, city: 5, better: 4, urban: 3, break: 2, geographical: 2, well: 3, transparent: 2, provide: 5, professionals: 2, doctors: 5, expertise: 2, bulk: 2, helping: 2, types: 4, device: 10, shifted: 2, stents: 2, meet: 3, estimated: 2, price: 7, grown: 3, brands: 3, home: 2, compete: 3, provincial: 3, governments: 2, followed: 2, various: 3, joints: 2, goal: 2, centralized: 2, towards: 6, jiangsu: 3, reported: 3, falls: 2, guizhou: 2, yunnan: 2, henan: 2, provinces: 3, alliance: 2, fees: 2, designed: 2, locally: 2, state: 3, equipment: 3, achieved: 2, manufactures: 2, imports: 2, equal: 6, customs: 2, review: 2, food: 2, magazine: 2, exceeding: 4, includes: 4, following: 2, szse: 6, established: 2, july: 2, options: 2, exit: 2, second: 3, raising: 4, launches: 2, breakthroughs: 2, cautious: 2, able: 3, cycle: 2, currently: 2, capitalization: 2, nearly: 6, trading: 2, postive: 2, remegen: 2, innocare: 2, venus: 2, horizon: 2, zelgen: 2, peijia: 2, akeso: 2, text: 2, regional: 3, hebei: 2, tianjin: 3, mongolia: 3, chains: 2, venues: 2, future: 3, concept: 3, middle: 2, dynamic: 2, controlling: 2, preventing: 2, returned: 2, worth: 2, technologies: 3, offerings: 4, corresponding: 2, impact: 3, near: 2, externalities: 2, economy: 4, incomes: 2, place: 3, shift: 3, bureau: 2, control: 6, base: 2, remain: 4, cooperating: 2, injecting: 2, firms: 13, reduced: 3, costs: 3, analysis: 2, accelerating: 3, efficiency: 4, enabling: 2, supports: 2, winning: 3, margins: 2, developing: 2, keep: 2, competitive: 4, might: 3, tough: 2, throughout: 2, added: 2, therefore: 2, facilities: 2, right: 2, scale: 2, network: 5, organizations: 5, askci: 2, eventually: 3, cheaper: 2, offers: 3, ever: 2, precise: 2, recruitment: 2, faster: 2, room: 6, specialist: 6, integrate: 2, sized: 2, less: 3, survive: 2, cash: 3, flow: 2, practices: 2, suzhou: 7, systems: 2, branding: 3, emphasize: 2, consumption: 2, upgrading: 2, segmented: 2, privatization: 6, zibo: 3, zichuan: 2, january: 3, welfare: 3, property: 9, luoyang: 9, carried: 2, signed: 2, rights: 5, transfer: 2, officially: 2, suqian: 5, privatized: 2, failed: 3, instead: 2, fairness: 2, within: 2, opinion: 2, provider: 2, vision: 2, junyao: 2, positioning: 2, point: 3, yorhe: 2, fluid: 2, intelligent: 2, hanshang: 2, spectrum: 2, seventh: 2, census: 4, aged: 2, professional: 5, acceleration: 2, dual: 2, shares: 4, corporations: 2, materials: 2, limited: 6, employees: 3, acquired: 3, least: 3, provided: 2, evidence: 2, advisory: 9, mandate: 2, part: 2, entity: 4, units: 2, parent: 2, shareholders: 2, partial: 2, form: 2, portfolios: 2, code: 2, undeveloped: 2, licenses: 2, https: 38, http: 12, february: 4, cgtn: 3, economist: 2, unit: 6, matt: 2, forum: 2, action: 2, email: 8, audit: 3, assurance: 3, consulting: 3, legal: 2, office: 5, hefei: 2, tower: 8, road: 18, pacific: 3, jinan: 2, plaza: 5, macau: 3, street: 2, nanjing: 4, ningbo: 2, sanya: 3, east: 5, shenyang: 2, avenue: 3, xiamen: 2, block: 3, zone: 2, zhengzhou: 2, changsha: 2, dalian: 2, guangzhou: 2, touche: 2, tohmatsu: 2, dttl: 9, member: 8, entities: 10, collectively: 3, legally: 2, separate: 3, independent: 3, firm: 2, liable: 2, clients: 2, please: 3, learn: 3, matters: 2, communication: 4, none: 2